Incorporating the Principles of Self-Management into Treatment of Dysarthria Associated with Parkinson's Disease.
Kathryn Yorkston, Carolyn Baylor, Deanna Britton
PMID 28618444WHAT IT FOUND
People with Parkinson's disease and dysarthria described speech therapy as tools, not a cure.
They valued realistic conversation and clinician feedback, disliked boring exercises, and wanted help for families, cognition, and keeping up practice.
Key findings
01Participants entered speech treatment with modest goals, including some improvement and ways to manage ongoing problems.
02Most described learning exercises aimed at making speech louder, and opinions about benefit were mixed.
03Participants described therapy as tools they had to keep using, and wanted more attention to family support, cognitive changes, and maintaining gains.
STILL TO COME
How it was doneWhat they foundWhat it means for SLPs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
Only 11 participants' experiences are summarized, and their speech treatment was not controlled, so the paper cannot show that any treatment caused change. Participants were English-speaking, community-dwelling, married, and passed a cognitive screening, so the findings may not apply to people living alone, without English, or with cognitive impairment. The paper mixes interview findings with expert recommendations about self-management; the recommendations are not tested in this article. The community treatments were described only as current standard of care, so specific therapy content, dose, and clinician qualifications were not standardized or reported.
Declared interests
No conflicts-of-interest declaration is provided in the supplied text. The metadata says the article was supported by NIH extramural research.
The easy way to misread this
Do not read this as evidence that self-management speech therapy improves dysarthria. The paper reports experiences from 11 participants whose treatment was not controlled and offers conceptual recommendations, not tested outcomes.